Key result
Extended-spectrum antibiotics show no benefit over narrow-spectrum antibiotics for preventing pediatric surgical site infections.
Why the study?
There is a paucity of high-quality evidence comparing extended versus narrow-spectrum antibiotics for preventing surgical site infections in children with uncomplicated appendicitis.
Does piperacillin/tazobactam reduce 30-day surgical site infections and hospital revisits compared to narrow-spectrum antibiotics in children with uncomplicated appendicitis?
Population
1389 children undergoing appendectomy for uncomplicated appendicitis at 17 hospitals
Comparison
Extended-spectrum piperacillin/tazobactam vs narrow-spectrum cefoxitin or ceftriaxone with metronidazole
Design
Propensity-matched cohort study
Follow-up
30-day
Authors
Loading...
Supports narrow-spectrum antibiotics in pediatric appendicitis; leaves open need for randomized confirmation before practice change.
Cohort (n=1,389)
Yes
Does piperacillin/tazobactam reduce 30-day surgical site infections and hospital revisits compared to narrow-spectrum antibiotics in children with uncomplicated appendicitis?
Odds Ratio: 1.05 (95% CI 0.34–3.26)
Absolute Event Rate: 2.4% vs 1.8%
Extended-spectrum antibiotics do not reduce surgical site infections or hospital revisits compared to narrow-spectrum antibiotics in children with uncomplicated appendicitis.
Cameron et al. (2017) conducted a cohort in Uncomplicated appendicitis (n=1,389). Extended-spectrum antibiotics (piperacillin/tazobactam) vs. Narrow-spectrum antibiotics (cefoxitin or ceftriaxone with metronidazole) was evaluated on 30-day surgical site infection (SSI) (OR 1.05, 95% CI 0.34-3.26). Extended-spectrum antibiotics were not associated with lower rates of 30-day surgical site infection compared with narrow-spectrum antibiotics in children (2.4% vs 1.8%; OR 1.05, 95% CI 0.34-3.26).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: